Grants and Contracts Details
Description
There is a significant gap in clinical knowledge on the applicability of targeted therapies and the
prognostic value of molecular profiling determinants in pediatric brain tumor patients. University of
Kentucky Research Foundation (UKRF) shall conduct a prospective study of next generation sequencing
and germline testing for all pediatric brain tumor patients in the Commonwealth of Kentucky.
Understanding regional difference in genetic expression may yield significant contributions in daily
clinical practice. Their multidisciplinary and multi-institutional approach will create a network of
providers to ensure all patients diagnosed in Kentucky undergo genetic testing, and each case will be
discussed during pediatric molecular tumor board if actionable mutations are found. The information
from this testing will be included in a state-wide population registry, that will allow for future
retrospective studies on outcomes and will help in understanding these diseases in the patient
population.
Status | Finished |
---|---|
Effective start/end date | 5/21/24 → 6/30/24 |
Funding
- KY Cabinet for Health and Family Services: $6,627.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.